APA (7th ed.) Citation

JS, C., KM, R., YY, C., JS, H., TS, Y., YC, L., . . . RH, K. (2009). A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer. Cancer Chemotherapy & Pharmacology, 63(5), 819. https://doi.org/10.1007/s00280-008-0797-4

Chicago Style (17th ed.) Citation

JS, Chen, et al. "A Multiple-center Phase II Study of Biweekly Oxaliplatin and Tegafur-uracil/leucovorin for Chemonaive Patients with Advanced Gastric Cancer." Cancer Chemotherapy & Pharmacology 63, no. 5 (2009): 819. https://doi.org/10.1007/s00280-008-0797-4.

MLA (9th ed.) Citation

JS, Chen, et al. "A Multiple-center Phase II Study of Biweekly Oxaliplatin and Tegafur-uracil/leucovorin for Chemonaive Patients with Advanced Gastric Cancer." Cancer Chemotherapy & Pharmacology, vol. 63, no. 5, 2009, p. 819, https://doi.org/10.1007/s00280-008-0797-4.